CAS 1229575-09-0

Lenzilumab

CAS: 1229575-09-0

Lenzilumab (KB 003) is a humanized GM-CSF neutralizing antibody for the study of COVID-19.

Reinheit: 98.9% (SDS-PAGE); 98.5% (SEC-HPLC) - 98.9% (SDS-PAGE); 98.5% (SEC-HPLC)

Farbe und Form: Liquid

Molekulargewicht: 146.81 kDa

Ref: TM-T76751

Lenzilumab

CAS: 1229575-09-0

Anti-Human CSF2 Monoclonal Antibody

Ref: 3D-CLA1367